Strategies for Testing Hemocompatibility and Potential Upcoming Changes
February 23, 2022 |
Presenter: Christopher Pohl
Blood-contacting devices must be assessed to understand how the interactions of the device with the patient’s blood do not pose a safety risk to the patient. What are some tests that need to be considered for a hemocompatibility assessment? What are some approaches that can be used to determine the endpoints that need to be evaluated? What new expectations and tests could be coming? Watch this video to learn more.
Christopher Pohl has been in the medical-device field for 9 years. He has worked for a variety of companies and positions, including in R&D, as a biocompatibility engineer, and as a toxicologist. He has been with Nelson Labs for over 2 years, during which time he has assessed medical devices, written toxicological risk assessments, and supported biocompatibility and hemocompatibility testing and evaluations. He was also a Peace Corps volunteer for 2 years. He received his bachelor's degree in materials science and engineering from Boise State University. Currently he is working towards a master's degree in pharmacology and toxicology.